827 related articles for article (PubMed ID: 22129499)
1. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
2. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
3. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H
Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317
[TBL] [Abstract][Full Text] [Related]
5. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
6. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report.
Suemitsu R; Maruyama R; Nishiyama K; Okamoto T; Wataya H; Seto T; Ichinose Y
Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):109-11. PubMed ID: 18414349
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
[TBL] [Abstract][Full Text] [Related]
10. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
[TBL] [Abstract][Full Text] [Related]
11. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Himpe U; Deroose CM; Leyn PD; Verbeken E; Vansteenkiste J
J Thorac Oncol; 2009 Jan; 4(1):107-8. PubMed ID: 19096317
[TBL] [Abstract][Full Text] [Related]
12. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.
Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U
J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515
[TBL] [Abstract][Full Text] [Related]
13. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
[TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Shin V; Bhargava P; Brown J; Ames ED; Kang P
Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
[TBL] [Abstract][Full Text] [Related]
15. Bronchogenic carcinoid tumours that are 18F-fluorodeoxyglucose avid on positron emission tomography.
Hunt BM; Horton MP; Vallières E
Eur J Cardiothorac Surg; 2014 Mar; 45(3):527-30. PubMed ID: 24047710
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG
Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139
[TBL] [Abstract][Full Text] [Related]
19. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
[TBL] [Abstract][Full Text] [Related]
20. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Collaud S; Lardinois D; Tischler V; Steinert HC; Stahel R; Weder W
Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
